Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Receptor protein-tyrosine kinases (RTKs) are a major class of transmembrane cell surface receptors that possess intrinsic enzymatic activity, specifically the ability to phosphorylate tyrosine residues on themselves and other proteins. They serve as high-affinity receptors for many polypeptide growth factors, cytokines, and hormones. Ligand binding induces dimerization and autophosphorylation, leading to activation of downstream signaling pathways such as Ras/MAPK and PI3K/Akt, regulating cell growth, differentiation, metabolism and motility. Dysregulation is frequently implicated in cancer.
Tyrosine kinase inhibition
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Receptor Protein-Tyrosine Kinase (RTK).